skip to Main Content
Movendo Technology

Press releases

Sergio Dompè invests 10 millions to launch Movendo Technology, the IIT start-up specialized in robotic rehabilitation

  • Press releases - 6 November 2016
media-header_2

Break even in 3 years and 100 employees in 5. First industrial plant set in Genoa. hunova – the first robotic rehabilitation device – will be marketed worldwide from 2017 starting from Europe and the US. Already CE certificated and shortly FDA too, it is already in use in several hospitals and rehabilitation centers in Italy and the first clinical contacts with the USA have started.

Sergio Dompé, from Milan, born in 1955, President of the Dompé Pharmaceutical Group, with offices in the US and in Europe, with about 500 employees and an investment in Research of about 50 million euros per year, has signed an agreement with IIT – Italian Institute of Technology – for the development of the start up Movendo Technology. This agreement will become effective only after 60 days of observation period by the supervising Ministries of the Economy and Finance and of Education, University and Research, as required by the legislation that regulates IIT start-ups.

The initial investment of 10 million euros allocated by Sergio Dompé, will be used to lay the groundwork for the birth of a new ‘made in Italy’ high-tech industrial reality. The new company will develop, produce and market innovative medical devices and its first industrial plant will be set in Genoa, nearby IIT, in which will start the production and the marketing of the first product (hunova), in Europe and US.

The investment by the enterpreneur Dompé is in line with the strategy of the homonym industrial group, that invests 25% of the revenue in research and develop and strongly believes in innovation.

hunova will be principally proposed to clinics in orthopedic, neurological, geriatric and sport physiotherapy centers and rehabilitation facilities. Medical robotic devices market is growing quickly worldwide and it is estimated that it will reach a total value of 5 billion dollars in the next 5 years. Business plan forecast break even in 3 years with a total of 100 employees in 5 years (from the initial 30). IIT will have an interest on the start up based on the investment done and it will also receive royalties on the intellectual property of the devices sold.

Movendo Technology is a company born from Simone Ungaro, Carlo Sanfilippo and Jody Saglia’s and from the work of a team of technicians and engineers of approximately 20 people. Movendo Technology which will establish its first industrial plant in Genoa, will start its business at the beginning of 2017, with the production and marketing of hunova, the robotic platform for rehabilitation and functional assessment of motor skills of lower limbs and trunk.

hunova, whose technologies are covered by international patents granted by IIT, and that has already received the CE certificate for Europe and shortly will also receive the FDA for the US, is a medical robotic device able to assist the physiotherapist in the treatment of ankle, hip knee and spine. The competitive advantage of this technology is double: on one side hunova is able to collect a significant amount of data on the patient’s biomechanics, monitoring their progress on time and on the other side it offers direct assistance to the patient through a robotic system that guides the patient, offering a wide range of rehabilitation protocols in the form of games. It consists of two electromechanical platforms sensorized with two degrees of freedom, one at the level of the feet and one at the level of the seat. The device integrates force sensors to regulate the interaction with the patient and a wireless sensor placed on the trunk of the subject that allows to control the movement of the patient’s torso.  hunova exercises are accompanied by graphic applications, very similar to simple video games, with which the patient interacts to complete the exercise. That’s how hunova allows to extend and develop the re-education practices traditionally used in an intensively and repeatable way, and offers objective parameters to evaluate patient’s recovery, personalization of care and effectiveness of therapy. The first hunova clinical trial on post-stroke patients, at the Rehabilitation Center of the Santa Corona Hospital in Pietra Ligure (SV), is currently in progress. Twenty of the expected thirty patients have been enrolled: preliminary feedbacks of patients and doctor are positive. Further clinical trials will start soon at the Galliera Hospital in Genoa in the orthopedic and geriatric field and also at the Inail Motor Rehabilitation Center of Volterra in the post-accident orthopedic field. Besides, contacts and information exchanges have started with leading clinical centers in northern Europe and in the US. These collaborations will be helpful to launch further trials and clinicals validations for product testing and optimization, extending expanding the areas of application over time.

The idea of Movendo Technology was born in the joint lab of IIT and INAIL (2013), called Rehab Technologies. The joint laboratory, which will continue its product research and development activities through close and effective collaboration with INAIL, is dedicated to the development of prosthetic and orthotic devices.

The devices under construction with INAIL are currently represented by a light, robust and low-cost robotic hand prosthesis and an exoskeleton that will help people with paralysis of the lower limbs to walk or to rehabilitate stroke patients.

Back To Top